41 articles
Chad Worz, PharmD, BCGP, FASCP, Executive Director and Chief Executive Officer of the American Society of Consultant Pharmacists (ASCP) discusses a new ...
Matthew Old, MD, Director of the Department of Otolaryngology–Head and Neck Surgery at The James, Ohio State University, Comprehensive Cancer Center d...
Peter Berglund, Chief Scientific Officer of HDT Bio, discusses the development of a next-generation RNA vaccine platform for infectious diseases and can...
Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda discusses the dengue program and the European Commission (EC) approval of t...
Ethan Settembre, PhD, Vice President, Research, CSL R&D Seqirus Vaccines Innovation Unit and study author, discusses key findings from the data publishe...
Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda discusses the news that Takeda’s dengue vaccine candidate, TAK-003, was r...
Jan Poolman, Head Bacterial Vaccine Discovery and Early Development at Janssen Infectious Diseases and Vaccines, at the Janssen Pharmaceutical Companies...
Daniel Faden, MD, Assistant Professor of Otolaryngology-Head and Neck Surgery, Harvard Medical School discusses his research on patient knowledge and op...
Returning guest, Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda, discusses the approval of the company’s dengue vaccine,...
Gregg Sylvester, Chief Health Officer at CSL Seqirus, one of the world’s largest influenza providers, discusses the CDC’s Advisory Committee on Imm...